tiprankstipranks
Traws Pharma (TRAW)
NASDAQ:TRAW

Traws Pharma (TRAW) Technical Analysis

1,798 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Traws Pharma’s (TRAW) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Traws Pharma is a Buy.
Traws Pharma’s (TRAW) 20-Day exponential moving average is 0.57, while Traws Pharma’s (TRAW) share price is $0.465, making it a Sell.
Traws Pharma’s (TRAW) 50-Day exponential moving average is 0.63, while Traws Pharma’s (TRAW) share price is $0.465, making it a Sell.

Traws Pharma (TRAW) Pivot Points

Jun 22, 2024, 08:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.37
0.40
0.44
0.46
0.50
0.52
0.56
Fibonacci
0.40
0.42
0.44
0.46
0.49
0.50
0.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Traws Pharma (TRAW) Moving Averages

Jun 22, 2024, 08:21 AM
Period
Simple
Exponential
MA5
0.50Sell
0.50Sell
MA10
0.57Sell
0.54Sell
MA20
0.58Sell
0.57Sell
MA50
0.63Sell
0.63Sell
MA100
0.72Sell
0.68Sell
MA200
0.71Sell
0.73Sell
Traws Pharma’s (TRAW) 10-Day exponential moving average is 0.54, while Traws Pharma’s (TRAW) share price is $0.465, making it a Sell.
Traws Pharma’s (TRAW) 100-Day exponential moving average is 0.68, while Traws Pharma’s (TRAW) share price is $0.465, making it a Sell.
Traws Pharma’s (TRAW) stock price is $0.465 and Traws Pharma’s (TRAW) 50-day simple moving average is 0.63, creating a Sell signal.
Traws Pharma’s (TRAW) stock price is $0.465 and Traws Pharma’s (TRAW) 100-day simple moving average is 0.72, creating a Sell signal.
Traws Pharma’s (TRAW) stock price is $0.465 and Traws Pharma’s (TRAW) 200-day simple moving average is 0.71, creating a Sell signal.

Traws Pharma (TRAW) Technical Indicators

Jun 22, 2024, 08:21 AM
Name
Value
Implied Action
RSI (14)
29.60
Buy
STOCH (9,6)
10.84
Buy
STOCHRSI (14)
10.84
Buy
MACD (12,26)
-0.04
Buy
ADX (14)
32.34
Neutral
Williams %R
-86.21
Buy
CCI (14)
-199.75
Buy
ATR (14)
0.06
-
Ultimate Oscillator
43.30
Neutral
ROC
-19.30
Sell
Traws Pharma’s (TRAW) Relative Strength Index (RSI) is 29.60, creating a Buy signal.
Traws Pharma’s (TRAW) Trend Strength Indicator (ADX) is 32.34, creating a Neutral signal.
Traws Pharma’s (TRAW) Commodity Channel Index (CCI) is -199.75, creating a Buy signal.
Traws Pharma’s (TRAW) Price Rate of Change (ROC) is -19.30, creating a Sell signal.

FAQ

Is TRAW a Buy, Hold, or Sell?
Based on TRAW’s technical indicators, TRAW is a Sell.
    What is TRAW’s RSI (14)?
    TRAW’s RSI (14) is 29.60, which suggests TRAW is a Buy.
      What is TRAW’s MACD?
      TRAW’s MACD is -0.04, which suggests TRAW is a Buy.
        What is TRAW’s 5-day moving average?
        TRAW’s 5-day moving average is 0.50, which suggests TRAW is a Sell.
          What is TRAW’s 20-day moving average?
          TRAW 20-day moving average is 0.58, which suggests TRAW is a Sell.
            What is TRAW’s 50-day moving average?
            TRAW’s 50-day moving average is 0.63, which suggests TRAW is a Sell.
              What is TRAW’s 200-day moving average?
              TRAW’s 200-day moving average is 0.71, which suggests TRAW is a Sell.
                What is TRAW’s Williams % R (14)?
                TRAW’s Williams % R (14) is -86.21, which suggests TRAW is a Buy.
                  What is TRAW’s CCI (14)?
                  TRAW’s CCI (14) is -199.75, which suggests TRAW is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis